Describe key pre-operative biometric, corneal, and patient-reported factors that inform suitability for presbyopia-correcting IOL implantation. Apply stepwise, evidence-based IOL selection strategies to match presbyopia-correcting IOL designs with patient visual needs and tolerance of optical trade-offs. Evaluate presbyopia-correcting IOL selection options in complex clinical scenarios, such as post-refractive surgery or corneal irregularity, to optimize refractive outcomes and minimize secondary interventions.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 124 S. Franklin Street
Pricing
89% of listed courses are free
25 of 28 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiothoracic Surgery
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Medical Genetics & Genomics
- Medical Oncology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Orthopaedic Trauma
- Pulmonary Disease
- Surgical Critical Care
- Surgical Oncology
- Thoracic Surgery
- Cardio-Vascular
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedJul 9, 2026
-
Last day to claim creditJul 10, 2027 9 months left
-
touchIME, USF Health Evolving Paradigms in PNH Management: Interpreting the Latest Data
-
touchIME, USF Health Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies
-
touchIME, USF Health Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management
